About Mark Betteridge & Associates
Mark Betteridge & Associates is a venture capital firm founded in 2015. It is primarily based out of Kelowna, Canada. It primarily invests in Canada based startups. Its investments are spread across a wide range of sectors from Life Sciences to Food and Agriculture Tech and Enterprise Applications. Overall, Mark Betteridge & Associates portfolio has seen 1 IPO and 1 acquisition, namely Daiya Foods and XBiotech.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Portfolio IPOs
Portfolio Acquisitions
Portfolio Soonicorns
Mark Betteridge & Associates' List of Top Investments
Mark Betteridge & Associates has a portfolio of 9 companies. Their most notable investments include Terramera and Daiya Foods.Their portfolio spans across Canada, United States and Mexico. They have invested in Life Sciences, Food and Agriculture Tech, Enterprise Applications and 9 other sectors. Here is the list of top investments by Mark Betteridge & Associates:
1. Terramera
Developer of biological crop protection formulations and soil intelligence technologies. They offer solutions for biological actives, delivery technologies, and stability enhancers. The company provides soil measurement and analysis, using sensing, signal processing, machine learning, and computational chemistry. The company focuses on sustainable agriculture practices.
Key facts about Terramera
- Founded Year: 2010
- Location: Vancouver (Canada)
- Stage: Series C
- Total Funding till date: $64.9M
- Employee Count: 24 as on May 31, 2026
- Investors: Western Technology Investment, Bold Capital Partners and 22 Others
- Latest Funding Round: Series C, Jan 12, 2023, $*****
- Highlight: Editors' Pick
2. Daiya Foods
Manufacturer of plant-based cheese, pizzas, mac and cheese, sauces, and dressings. The company provides dairy-free alternatives, including cheese shreds, slices, and sticks. It offers plant-based pizzas with thin crusts and balanced toppings. The company also makes dairy-free mac and cheese, along with a variety of sauces and dressings.
Key facts about Daiya Foods
- Founded Year: 2008
- Location: Vancouver (Canada)
- Stage: Acquired
- Total Funding till date: $775K
- Employee Count: 207 as on May 31, 2026
- Investors: Northwood Ventures, Mark Betteridge & Associates and 1 Other
- Latest Funding Round: Seed, Mar 2010, $*****
- Highlight: Acquired
3. NEXE
Key facts about NEXE
- Founded Year: 2014
- Location: Windsor (Canada)
- Stage: Funding Raised
- Employee Count: 20 as on May 31, 2026
- Investors: Canadian Space Agency, Varshney Capital and 5 Others
- Latest Funding Round: Grant (prize money), Jan 25, 2021, $*****
4. XBiotech
XBiotech is focussed on the development of therapeutic antibodies for the range of indications. Based on its True Human proprietary technology which derives antibodies without modification from individuals, it is developing its pipeline of antibody therapies for oncology, inflammatory and infectious diseases. Its lead candidate Xilonix which specifically target and neutralize interleukin-1 alpha (IL-1α) is currently in phase 3 clinical trials for colorectal cancer. It also has drugs in other development stages for cardiovascular disorders, psoriasis, acne, diabetes and infectious diseases.
Key facts about XBiotech
- Founded Year: 2005
- Location: Austin (United States)
- Annual Revenue: $1M - $10M as on Dec 31, 2022
- Stage: Public
- Employee Count: 98 as on May 31, 2026
- Investors: Mark Betteridge & Associates
- Highlight: Public
Phemi Health Systems offers Phemi Agile, a big data repository for single departmental implementations ranging from laboratory reports to patient information to gene sequences; Phemi Clinical, a customizable care management platform that improves clinic productivity and patient outcomes by automating ambulatory care processes; and Phemi Central, a big data warehouse that transforms data into analytics-ready digital assets for researchers, analysts, and administrators in healthcare and public sector organizations.
Key facts about PHEMI Health Systems
- Founded Year: 2013
- Location: Vancouver (Canada)
- Stage: Series B
- Total Funding till date: $25M
- Employee Count: 5 as on May 31, 2026
- Investors: Amplitude, Quark Venture and 10 Others
- Latest Funding Round: Series B, Jun 27, 2017, $*****
IPOs and Publicly Listed companies in Mark Betteridge & Associates' Portfolio
1 of Mark Betteridge & Associates' portfolio company became public - XBiotech. It got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Apr 2015 at marketcap of $603MHere are Mark Betteridge & Associates' portfolio companies that went public:
Filter this listCompany | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 15, 2015 | - | - | 6319 |
Acquired companies in Mark Betteridge & Associates' Portfolio
1 company from Mark Betteridge & Associates' portfolio has been acquired. The most recent acquisition was Daiya Foods in Jul 2017 by Otsuka for $*****.Here are Mark Betteridge & Associates' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Jul 27, 2017 | - | - | 2916 |
